Unplanned hospitalizations or readmissions · Percutaneous nephrolithotomy
1 finding from 1 review
Length of hospital stay · Percutaneous nephrolithotomy
1 finding from 1 review
Stone‐free rate · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in stone‐free rate compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Thromboembolic events · Percutaneous nephrolithotomy
1 finding from 1 review
Adverse events · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in adverse events compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Secondary interventions · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in secondary interventions compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Major surgical complications · Percutaneous nephrolithotomy
Systemic TXA probably leads to lower major surgical complications compared with no TXA (placebo or usual care) (moderate certainty).
1 finding from 1 review
Minor surgical complications · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in minor surgical complications compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Unplanned hospitalizations or readmissions · Percutaneous nephrolithotomy
It is very uncertain whether systemic TXA changes unplanned hospitalizations or readmissions compared with no TXA (placebo or usual care) (very low certainty).
1 finding from 1 review
Length of hospital stay · Percutaneous nephrolithotomy
1 finding from 1 review
Intervention not reported
Estimated total blood loss (mL) · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in estimated total blood loss (mL) (low certainty).
1 finding from 1 review
Intervention not reported
Number of transfused units of red blood cell (RBC) · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in number of transfused units of red blood cell (RBC) (low certainty).
1 finding from 1 review
Intervention not reported
Number of transfused units of plasma · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in number of transfused units of plasma (low certainty).
1 finding from 1 review
Intervention not reported
Rate of RBC transfusion (total number of participants who required at least one unit of red blood cell transfusion) Time: perioperative and postoperative periods · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in rate of RBC transfusion (total number of participants who required… (low certainty).
1 finding from 1 review
Intervention not reported
Rate of plasma transfusion (total number of participants who required at least one unit of plasma transfusion) Time: perioperative and postoperative periods · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in rate of plasma transfusion (total number of participants who… (low certainty).
1 finding from 1 review
Intervention not reported
Reoperation (Number of participants with at least one reoperation) Time: perioperative periods · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes reoperation (Number of participants with at least one reoperation)… (very low certainty).
1 finding from 1 review
Intervention not reported
Readmission (Number of participants with at least one readmission) Time: perioperative periods) · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes readmission (Number of participants with at least one readmission)… (very low certainty).
1 finding from 1 review
Intervention not reported
Venous thromboembolic events (number of participants with at least one venous thromboembolic events) Time: 5‐week · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes venous thromboembolic events (number of participants with at least… (very low certainty).
1 finding from 1 review
Intervention not reported
Arterial thromboembolic events (number of participants with at least one venous thromboembolic events) Time: 5‐week · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes arterial thromboembolic events (number of participants with at least… (very low certainty).
1 finding from 1 review